» Authors » Marie-Paule Merville

Marie-Paule Merville

Explore the profile of Marie-Paule Merville including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 48
Citations 1615
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Napp A, Houbart V, Demelenne A, Merville M, Crommen J, Dumoulin M, et al.
Electrophoresis . 2018 Aug; 39(23):3022-3031. PMID: 30157293
Parkinson's disease (PD) is a frequent degenerative disorder that is diagnosed based on clinical symptoms. When the first symptoms appear, more than 70% of the dopaminergic cells are already lost....
2.
Houbart V, Cobraiville G, Servais A, Napp A, Merville M, Fillet M
Bioanalysis . 2015 Nov; 7(21):2789-99. PMID: 26595680
Background: Dried blood analysis experiences a growing interest due to practical, ethical and financial advantages compared with classical wet plasma or serum analysis. Besides classical DBS, new alternatives are commercialized...
3.
Deroyer C, Magne J, Moonen M, Le Goff C, Dupont L, Hulin A, et al.
Clin Proteomics . 2015 Sep; 12:25. PMID: 26405438
Background: Mitral regurgitation is a frequent valvular heart disease affecting around 2.5 % of the population with prevalence directly related to aging. Degeneration of mitral valve is broadly considered as...
4.
de Bock M, Beguin Y, Leprince P, Willems E, Baron F, Deroyer C, et al.
Talanta . 2014 May; 125:265-75. PMID: 24840443
Acute graft-versus-host disease (aGVHD) remains a life-threatening complication of hematopoietic stem cell transplantation (HSCT) therefore limiting its application. To optimize the management of aGVHD and reduce therapy-related toxicity, early specific...
5.
Deroyer C, Renert A, Merville M, Fillet M
Autophagy . 2014 May; 10(7):1229-40. PMID: 24819607
To date, precise roles of EMD (emerin) remain poorly described. In this paper, we investigated the role of EMD in the C16-ceramide autophagy pathway. Ceramides are bioactive signaling molecules acting...
6.
de Bock M, Fillet M, Hannon M, Seidel L, Merville M, Gothot A, et al.
PLoS One . 2013 Feb; 8(2):e55876. PMID: 23437070
Background: We analysed kinetics of IL-7 and IL-15 levels in 70 patients given peripheral blood stem cells after nonmyeloablative conditioning. Methods: EDTA-anticoagulated plasma and serum samples were obtained before conditioning...
7.
de Seny D, Sharif M, Fillet M, Cobraiville G, Meuwis M, Maree R, et al.
Ann Rheum Dis . 2011 Mar; 70(6):1144-52. PMID: 21362709
Objective: Knee osteoarthritis (OA) is a heterogeneous, complex joint pathology of unknown aetiology. Biomarkers have been widely used to investigate OA but currently available biomarkers lack specificity and sensitivity. Therefore,...
8.
de Bock M, de Seny D, Meuwis M, Servais A, Quang Minh T, Closset J, et al.
Talanta . 2010 Aug; 82(1):245-54. PMID: 20685463
In most diseases, the clinical need for serum/plasma markers has never been so crucial, not only for diagnosis, but also for the selection of the most efficient therapies, as well...
9.
Keutgens A, Zhang X, Shostak K, Robert I, Olivier S, Vanderplasschen A, et al.
J Biol Chem . 2010 Jun; 285(33):25831-40. PMID: 20558726
The oncogenic protein BCL-3 activates or represses gene transcription through binding with the NF-kappaB proteins p50 and p52 and is degraded through a phospho- and GSK3-dependent pathway. However, the mechanisms...
10.
de Bock M, de Seny D, Meuwis M, Chapelle J, Louis E, Malaise M, et al.
J Biomed Biotechnol . 2009 Dec; 2010:906082. PMID: 20029632
Protein profiling using SELDI-TOF-MS has gained over the past few years an increasing interest in the field of biomarker discovery. The technology presents great potential if some parameters, such as...